Cargando…

Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study

BACKGROUND: Psoriasis is an inflammatory skin disease that may lead to comorbidities, including metabolic syndrome (MS). OBJECTIVE: We determined the prevalence of MS and its correlation with psoriasis duration, severity, and sleep quality in psoriasis patients. METHODS: A total of 112 subjects with...

Descripción completa

Detalles Bibliográficos
Autores principales: Tas, Betul, Kabeloglu, Vasfiye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172038/
https://www.ncbi.nlm.nih.gov/pubmed/34123557
http://dx.doi.org/10.5826/dpc.1103a49
_version_ 1783702466100985856
author Tas, Betul
Kabeloglu, Vasfiye
author_facet Tas, Betul
Kabeloglu, Vasfiye
author_sort Tas, Betul
collection PubMed
description BACKGROUND: Psoriasis is an inflammatory skin disease that may lead to comorbidities, including metabolic syndrome (MS). OBJECTIVE: We determined the prevalence of MS and its correlation with psoriasis duration, severity, and sleep quality in psoriasis patients. METHODS: A total of 112 subjects with chronic plaque psoriasis were studied. Demographics, MS parameters, disease duration, severity, and sleep quality were examined. The Psoriasis Area and Severity Index (PASI) and the Pittsburgh Sleep Quality Index (PSQI) were used to assess psoriasis severity and sleep quality, respectively. Presence of MS and its correlations with psoriasis duration, severity and sleep quality were investigated. RESULTS: Of 112 patients, 76 (67.8%) were diagnosed with MS. Of all patients, 74.1% had a high PASI, and 84.8% had a high PSQI. The mean values of psoriasis duration, body mass index, waist circumference, fasting glucose, HOMA-IR, triglyceride levels, blood pressure, PSQI, sleep latency, and daytime sleep dysfunction were significantly higher in the MS group than non-MS group, whereas the mean HDL level was lower. The prevalences of MS, high fasting glucose, and low HDL were significantly higher among female, but not male, patients with severe psoriasis (PASI >10) than those without severe psoriasis. Disease duration, high body mass index, waist circumference, blood pressure, fasting glucose, HOMA-IR, triglyceride levels, low HDL, and poor sleep quality were significantly correlated with the presence of MS. However, only waist circumference, fasting glucose, blood pressure, and low HDL were predictive of the development of MS. CONCLUSIONS: MS is common among psoriasis patients, and especially in females with advanced psoriasis, high fasting glucose, and low HDL levels. Besides diagnostic criteria of MS, a long duration of psoriasis, poor sleep quality and high-HOMA-IR correlate with the development of MS. High fasting glucose and low HDL levels may facilitate MS development in association with psoriasis severity in females.
format Online
Article
Text
id pubmed-8172038
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-81720382021-06-11 Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study Tas, Betul Kabeloglu, Vasfiye Dermatol Pract Concept Research BACKGROUND: Psoriasis is an inflammatory skin disease that may lead to comorbidities, including metabolic syndrome (MS). OBJECTIVE: We determined the prevalence of MS and its correlation with psoriasis duration, severity, and sleep quality in psoriasis patients. METHODS: A total of 112 subjects with chronic plaque psoriasis were studied. Demographics, MS parameters, disease duration, severity, and sleep quality were examined. The Psoriasis Area and Severity Index (PASI) and the Pittsburgh Sleep Quality Index (PSQI) were used to assess psoriasis severity and sleep quality, respectively. Presence of MS and its correlations with psoriasis duration, severity and sleep quality were investigated. RESULTS: Of 112 patients, 76 (67.8%) were diagnosed with MS. Of all patients, 74.1% had a high PASI, and 84.8% had a high PSQI. The mean values of psoriasis duration, body mass index, waist circumference, fasting glucose, HOMA-IR, triglyceride levels, blood pressure, PSQI, sleep latency, and daytime sleep dysfunction were significantly higher in the MS group than non-MS group, whereas the mean HDL level was lower. The prevalences of MS, high fasting glucose, and low HDL were significantly higher among female, but not male, patients with severe psoriasis (PASI >10) than those without severe psoriasis. Disease duration, high body mass index, waist circumference, blood pressure, fasting glucose, HOMA-IR, triglyceride levels, low HDL, and poor sleep quality were significantly correlated with the presence of MS. However, only waist circumference, fasting glucose, blood pressure, and low HDL were predictive of the development of MS. CONCLUSIONS: MS is common among psoriasis patients, and especially in females with advanced psoriasis, high fasting glucose, and low HDL levels. Besides diagnostic criteria of MS, a long duration of psoriasis, poor sleep quality and high-HOMA-IR correlate with the development of MS. High fasting glucose and low HDL levels may facilitate MS development in association with psoriasis severity in females. Mattioli 1885 2021-05-20 /pmc/articles/PMC8172038/ /pubmed/34123557 http://dx.doi.org/10.5826/dpc.1103a49 Text en ©2021 Tas and Kabeloglu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License BY-NC-4.0, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited.
spellingShingle Research
Tas, Betul
Kabeloglu, Vasfiye
Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study
title Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study
title_full Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study
title_fullStr Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study
title_full_unstemmed Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study
title_short Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study
title_sort prevalence of metabolic syndrome and its parameters and their correlations with psoriasis duration, severity, and sleep quality in psoriasis patients: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172038/
https://www.ncbi.nlm.nih.gov/pubmed/34123557
http://dx.doi.org/10.5826/dpc.1103a49
work_keys_str_mv AT tasbetul prevalenceofmetabolicsyndromeanditsparametersandtheircorrelationswithpsoriasisdurationseverityandsleepqualityinpsoriasispatientsacrosssectionalstudy
AT kabelogluvasfiye prevalenceofmetabolicsyndromeanditsparametersandtheircorrelationswithpsoriasisdurationseverityandsleepqualityinpsoriasispatientsacrosssectionalstudy